Delivery Order SPE2DB22D1017-SPE2DB25FG0CD
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Lispro 100 Unit/mL Pen 3mL at a firm fixed price of $1,036.86. The contract has a period of performance through March 12, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, with a ceiling value of $1,554.21 and an ultimate completion date of March 14, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
This contract award to Amerisourcebergen Drug Corp involves the delivery of Insulin Lispro 100 Unit/mL vials to the U.S. government. The contract has a ceiling value of $1,755.24 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency that procures medical supplies and equipment. This contract represents a Delivery Order against a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Insulin Lispro 100 Unit/mL Pen 3mL, a medication used to treat diabetes. The contract has a total ceiling value of $1,508.58 and was awarded on April 15, 2022, with an ultimate completion date of April 18, 2022. The contract is a firm fixed-price delivery order, and there is no set-aside designation...
This federal contract award, with a ceiling value of $1,312.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor to the U.S. government. The contract is for the delivery of Insulin Lispro 100 Unit/mL Pen, a critical medication, to support military treatment facilities and other government healthcare programs. This is a Firm Fixed Price delivery order contract with an ultimate completion date of August...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,652.05 firm fixed-price contract is for the delivery of Insulin Lispro 100 Unit/mL Pen 3mL, a critical diabetes management medication. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen is the prime contractor, and there are no noted subcontractors. The contract is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Lispro 100 Unit/mL Pen 3mL. The $1,094.10 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., doing business as AmerisourceBergen. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,912.60 firm fixed-price delivery order is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication used in the management of diabetes. The contract has an ultimate completion date of July 12, 2022 and was awarded on July 11, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564227795 - Insulin Lispro 100 Unit/mL Pens (3mL) with a firm fixed price of $2,965.50 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...